Physician Assistant · Albany, NY
NPI
1881662823
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
47 New Scotland Ave
Albany, NY, 12208
Phone (518) 262-3773
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
196 services
Medicare patients, 2024
88
Average age 63
Drug cost, 2024
$10.1M
9,287 prescriptions
Company payments, 2025
$119
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey K Claus was code 99214 (office e&m - established), 149 times for 78 patients. In total Jeffrey K Claus billed 196 services in 7 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 149 | 78 | $51.76 | $7,713 |
| 99215 Office E&M - Established | Facility | 20 | 15 | $78.76 | $1,575 |
| 99214 Office E&M - Established | Office | 12 | 12 | $51.44 | $617 |
By year: 2023 $2,584 for 50 services; 2024 $10K for 196 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey K Claus prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 1,045 prescriptions and refills. In total Jeffrey K Claus wrote 9,287 Medicare prescriptions that cost $10.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 1,045 | 1,098 | 138 | $4.3M |
| Atorvastatin Calcium Generic | 396 | 722 | 97 | $2,653 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 301 | 316 | 64 | $9,615 |
| Tivicay Dolutegravir Sodium | 280 | 288 | 39 | $669K |
| Descovy Emtricitabine/Tenofov Alafenam | 260 | 277 | 33 | $603K |
| Rosuvastatin Calcium Generic | 230 | 350 | 39 | $2,410 |
| Lisinopril Generic | 219 | 441 | 54 | $1,242 |
| Omeprazole Generic | 200 | 342 | 44 | $1,419 |
| Amlodipine Besylate Generic | 171 | 320 | 39 | $734 |
| Juluca Dolutegravir/Rilpivirine | 164 | 186 | 26 | $643K |
| Losartan Potassium Generic | 161 | 263 | 30 | $806 |
| Gabapentin Generic | 161 | 198 | 35 | $1,751 |
| Valacyclovir Valacyclovir Hcl | 158 | 237 | 40 | $5,975 |
| Prezcobix Darunavir/Cobicistat | 156 | 172 | 23 | $412K |
| Dovato Dolutegravir Sodium/Lamivudine | 134 | 136 | 17 | $402K |
Brand drugs: 3,522 claims; generic drugs: 5,749 claims; opioid claims: 242.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey K Claus $119 ($119 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $119.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $119 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.